---
title: 'Manufacturing Daily Summary: What Happened on October 26, 2026'
headline: Reshoring puts medical device capacity under pressure
description: Medical device makers are acting on reshoring plans as manufacturing
  coverage examines GMP filling, process monitoring and complex therapeutics.
url: https://thebench.bio/news/manufacturing/2026-10-26
topic: manufacturing
date: '2026-10-26'
covers:
- '2026-10-26'
date_published: '2026-10-26T12:04:41Z'
date_modified: '2026-10-26T12:04:41Z'
tags:
- Industry
- Manufacturing
sources: 4
publisher: TheBench.Bio
---

# Manufacturing Daily Summary: What Happened on October 26, 2026

**Reshoring puts medical device capacity under pressure**

Medical device makers are acting on reshoring plans as manufacturing coverage examines GMP filling, process monitoring and complex therapeutics.

## Today in brief

Medical device manufacturers are putting reshoring plans into practice and encountering capacity challenges. [1]

## Also worth knowing

- Moving aseptic filling from lab-scale work to GMP production brings regulatory, technical and operational changes. Choosing a fill-finish contract development and manufacturing organization is also part of the transition. [2]
- Real-time monitoring can improve control of bioprocessing. [3]
- Manufacturing challenges and solutions vary across antibody-drug conjugates, bispecifics, peptides and other protein and peptide therapeutics. [4]

## Sources

1. [Reshoring prompts crucial decisions for medical device manufacturers](<https://www.medtechdive.com/spons/reshoring-prompts-crucial-decisions-for-medical-device-manufacturers/833068/>), MedTech Dive, 2026-10-26
2. [Transitioning from lab bench to GMP: What research scientists should know about manual aseptic filling](<https://www.pharmaceutical-technology.com/sponsored/transitioning-from-lab-bench-to-gmp-what-research-scientists-should-know-about-manual-aseptic-filling/>), Pharmaceutical Technology, 2026-10-26
3. [Bioprocessing observability: why real-time monitoring matters](<https://www.pharmavoice.com/spons/bioprocessing-observability-why-real-time-monitoring-matters/833811/>), PharmaVoice, 2026-10-26
4. [Novel protein and peptide therapeutics](<https://www.biopharmadive.com/spons/novel-protein-and-peptide-therapeutics/833429/>), BioPharma Dive, 2026-10-26

---

TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing.

[1]: <https://www.medtechdive.com/spons/reshoring-prompts-crucial-decisions-for-medical-device-manufacturers/833068/>
[2]: <https://www.pharmaceutical-technology.com/sponsored/transitioning-from-lab-bench-to-gmp-what-research-scientists-should-know-about-manual-aseptic-filling/>
[3]: <https://www.pharmavoice.com/spons/bioprocessing-observability-why-real-time-monitoring-matters/833811/>
[4]: <https://www.biopharmadive.com/spons/novel-protein-and-peptide-therapeutics/833429/>